Guillermo Luna, in Bellevue, NE - Counselor

Guillermo Luna, is a Counselor - Mental Health based in Bellevue, Nebraska. Guillermo Luna is licensed to practice in * (Not Available) (license number ) and his current practice location is 207 Galvin Rd N, Bellevue, Nebraska. He can be reached at his office (for appointments etc.) via phone at (402) 807-5117.

NPI number for Guillermo Luna is 1194438416 and his current mailing address is 207 Galvin Rd N, Bellevue, Nebraska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1194438416.

Contact Information

	Guillermo Luna,
	207 Galvin Rd N, Bellevue, NE 68005-4898
	(402) 807-5117
	Not Available

Healthcare Provider's Profile

Full Name	Guillermo Luna
Gender	Male
Speciality	Counselor - Mental Health
Location	207 Galvin Rd N, Bellevue, Nebraska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1194438416
Provider Enumeration Date: 01/02/2023
Last Update Date: 01/02/2023

Medical Identifiers

Medical identifiers for Guillermo Luna such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1194438416	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	(* (Not Available))	Secondary
101YM0800X	Counselor - Mental Health	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Guillermo Luna is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Guillermo Luna, 207 Galvin Rd N, Bellevue, NE 68005-4898 Ph: (402) 807-5117	Guillermo Luna, 207 Galvin Rd N, Bellevue, NE 68005-4898 Ph: (402) 807-5117

News Archive

Researchers discover key allergy gene

Together with colleagues from the Department of Dermatology and Allergy and the Center for Allergy and Environment (ZAUM) of the Technische Universitat Munchen, scientists at the Helmholtz Zentrum Munchen have pinpointed a major gene for allergic diseases. The gene was localized using cutting edge technologies for examining the whole human genome at the Helmholtz Zentrum Munchen.

Akorn enters agreement to acquire minority ownership in Aciex

Akorn, Inc., a niche specialty pharmaceutical company, today announced that it has entered into an agreement to acquire a minority ownership in Westborough, MA, based Aciex Therapeutics Inc., an ophthalmic drug development company with a focus on developing novel therapeutics to treat ocular diseases.

New study shows MRSA is no more expensive to treat than MSSA

A new study from the Center for Disease Dynamics, Economics & Policy, with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US-methicillin-resistant Staphylococcus aureus, known as MRSA-are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.

GI Dynamics' EndoBarrier Gastrointestinal Liner for pre-surgical weight loss treatment demonstrates safety

GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, today announced data which support the safety and efficacy of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus.

Guillermo Luna, - in Bellevue, NE